Wealthfront’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $236K | Buy |
+584
| New | +$236K | ﹤0.01% | 483 |
|
|
2018
Q2 | – | Sell |
-829
| Closed | -$285K | – | 518 |
|
|
2018
Q1 | $285K | Sell |
829
-213
| -20% | -$73.2K | ﹤0.01% | 443 |
|
|
2017
Q4 | $392K | Sell |
1,042
-551
| -35% | -$207K | ﹤0.01% | 396 |
|
|
2017
Q3 | $712K | Sell |
1,593
-222
| -12% | -$99.2K | 0.01% | 262 |
|
|
2017
Q2 | $891K | Buy |
1,815
+322
| +22% | +$158K | 0.01% | 169 |
|
|
2017
Q1 | $579K | Buy |
1,493
+289
| +24% | +$112K | 0.01% | 201 |
|
|
2016
Q4 | $442K | Buy |
1,204
+3
| +0.2% | +$1.1K | 0.01% | 219 |
|
|
2016
Q3 | $483K | Buy |
1,201
+614
| +105% | +$247K | 0.01% | 184 |
|
|
2016
Q2 | $205K | Sell |
587
-23
| -4% | -$8.03K | 0.01% | 338 |
|
|
2016
Q1 | $220K | Sell |
610
-416
| -41% | -$150K | 0.01% | 297 |
|
|
2015
Q4 | $557K | Buy |
1,026
+94
| +10% | +$51K | 0.02% | 132 |
|
|
2015
Q3 | $434K | Buy |
932
+103
| +12% | +$48K | 0.02% | 151 |
|
|
2015
Q2 | $423K | Buy |
829
+161
| +24% | +$82.2K | 0.02% | 133 |
|
|
2015
Q1 | $302K | Buy |
668
+168
| +34% | +$76K | 0.01% | 157 |
|
|
2014
Q4 | $205K | Buy |
500
+105
| +27% | +$43.1K | 0.01% | 210 |
|
|
2014
Q3 | $142K | Buy |
395
+250
| +172% | +$89.9K | 0.01% | 218 |
|
|
2014
Q2 | $45K | Sell |
145
-140
| -49% | -$43.4K | ﹤0.01% | 385 |
|
|
2014
Q1 | $87K | Buy |
+285
| New | +$87K | 0.01% | 153 |
|